A238120 logo

Aligned Genetics, Inc. Stock Price

KOSDAQ:A238120 Community·₩48.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A238120 Share Price Performance

₩0
-3180.00 (-100.00%)
₩0
-3180.00 (-100.00%)
Price ₩0

A238120 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet and fair value.

1 Risk
2 Rewards

Aligned Genetics, Inc. Key Details

₩17.2b

Revenue

₩5.4b

Cost of Revenue

₩11.8b

Gross Profit

₩8.5b

Other Expenses

₩3.3b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
235.94
68.77%
19.32%
6.9%
View Full Analysis

About A238120

Founded
2008
Employees
66
CEO
Yeon-Cheol Jung
WebsiteView website
alignedgenetics.com

Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea.

Recent A238120 News & Updates

These 4 Measures Indicate That Aligned Genetics (KOSDAQ:238120) Is Using Debt Safely

Nov 12
These 4 Measures Indicate That Aligned Genetics (KOSDAQ:238120) Is Using Debt Safely

Recent updates

No updates